B. Riley Cuts Earnings Estimates for Denali Therapeutics
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – B. Riley dropped their Q2 2025 EPS estimates for Denali Therapeutics in a report released on Wednesday, May 7th. B. Riley analyst M. Mamtani now forecasts that the company will earn ($0.86) per share for the quarter, down from their prior forecast of ($0.80). B. Riley currently […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – B. Riley dropped their Q2 2025 EPS estimates for Denali Therapeutics in a report released on Wednesday, May 7th. B. Riley analyst M. Mamtani now forecasts that the company will earn ($0.86) per share for the quarter, down from their prior forecast of ($0.80). B. Riley currently […]
